From Validation to Market Entry
Key milestones already achieved — and the next steps ahead.
Pre-clinical Validation
HeraWeave + OrthoWeave rodent models complete
$18M+ Backing
Institutional support secured before public raise
Wefunder Round Open
First goal hit with $218,856+ raised
Q4 2026
SMARTS™ system proof of concept complete
Q2 2027
SmartCoating™ / HeraWeave™ market entry
Join Early Investors Building The Future Of Personalized Regenerative Medicine.
Start with as little as $100 or discuss a larger investment opportunity directly.
“The biology is already there. Every patient carries the blueprint for their own repair. Smartweave was built to read it.”
Raj Malhotra
Serial founder. Inventor of surgical technologies. Built and scaled venture-backed companies globally. Started Smartweave to solve a design flaw the entire industry had normalized.
Built with Surgical, Scientific, and MedTech Expertise.
Craig Comiter, MD
Stanford Urology Professor · Victor A. Politano Award
Bertha Chen, MD
Stanford Urogynecology Co-Chief · NIH + CIRM grant recipient
Dr. Dmitriy Sheyn
Cedars-Sinai Orthopedic Research Lab · Tendon regeneration expert
Carlos Rivera-Velez, PhD, PE
COO · Former Stryker, Edwards Lifesciences, J&J